510(k) K231469
K231469 is an FDA 510(k) premarket notification submitted by Preanalytix GmbH for the device "PAXgene® Blood DNA Tube". The FDA issued a decision of Substantially Equivalent on June 21, 2023. The device falls under product code PJE (Blood/Plasma Collection Device For Dna Testing), a Class II device regulated under 21 CFR 862.1675. Preanalytix GmbH has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 21, 2023
- Date Received
- May 22, 2023
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Blood/Plasma Collection Device For Dna Testing
- Device Class
- Class II
- Regulation Number
- 862.1675
- Review Panel
- CH
- Submission Type
A blood collection device for DNA testing is an in vitro diagnostics device intended to collect and transport blood specimens to the laboratory for clinical DNA testing.